NYSE ARCA | ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 24.55% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 18.71% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.04% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.62% |
RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.53% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.49% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.43% |
CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.41% |
ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 4.13% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.06% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.00% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.52% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.08% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.28% |
PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.56% |
PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.43% |
CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 1.39% |
SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.17% |
OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.14% |